Montrusco Bolton Investments Inc. lowered its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 10.9% during the 4th quarter, HoldingsChannel reports. The fund owned 98,925 shares of the company’s stock after selling 12,081 shares during the period. Montrusco Bolton Investments Inc.’s holdings in Henry Schein were worth $6,913,000 as of its most recent SEC filing.
A number of other large investors have also bought and sold shares of the stock. Vanguard Group Inc. boosted its stake in Henry Schein by 3.0% during the second quarter. Vanguard Group Inc. now owns 8,086,317 shares of the company’s stock worth $1,479,959,000 after acquiring an additional 236,862 shares in the last quarter. FMR LLC boosted its stake in Henry Schein by 0.4% during the second quarter. FMR LLC now owns 6,921,367 shares of the company’s stock worth $1,266,749,000 after acquiring an additional 24,935 shares in the last quarter. BlackRock Inc. boosted its stake in Henry Schein by 1.8% during the second quarter. BlackRock Inc. now owns 5,696,685 shares of the company’s stock worth $1,042,607,000 after acquiring an additional 101,406 shares in the last quarter. Alecta Pensionsforsakring Omsesidigt boosted its stake in Henry Schein by 112.0% during the third quarter. Alecta Pensionsforsakring Omsesidigt now owns 5,313,980 shares of the company’s stock worth $435,693,000 after acquiring an additional 2,806,990 shares in the last quarter. Finally, Mackenzie Financial Corp boosted its stake in Henry Schein by 106.0% during the third quarter. Mackenzie Financial Corp now owns 3,938,233 shares of the company’s stock worth $322,896,000 after acquiring an additional 2,026,867 shares in the last quarter. 91.69% of the stock is currently owned by institutional investors and hedge funds.
Shares of Henry Schein, Inc. (HSIC) traded up $0.51 during trading on Friday, reaching $73.30. 1,251,800 shares of the company’s stock traded hands, compared to its average volume of 1,327,387. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.55 and a quick ratio of 0.86. The stock has a market capitalization of $11,750.00, a PE ratio of 21.12, a PEG ratio of 1.89 and a beta of 0.99. Henry Schein, Inc. has a twelve month low of $65.28 and a twelve month high of $93.50.
Henry Schein declared that its board has authorized a stock repurchase plan on Monday, September 18th that authorizes the company to buyback $400.00 million in shares. This buyback authorization authorizes the company to repurchase up to 6.3% of its shares through open market purchases. Shares buyback plans are typically a sign that the company’s leadership believes its shares are undervalued.
In other news, Director Barry J. Alperin sold 5,796 shares of the business’s stock in a transaction that occurred on Friday, December 1st. The shares were sold at an average price of $70.76, for a total transaction of $410,124.96. Following the completion of the transaction, the director now directly owns 48,172 shares of the company’s stock, valued at $3,408,650.72. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.19% of the stock is owned by insiders.
Several equities research analysts recently commented on the stock. Evercore ISI assumed coverage on shares of Henry Schein in a research note on Thursday, January 4th. They set an “outperform” rating and a $81.00 price objective on the stock. Zacks Investment Research raised shares of Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday, January 4th. Piper Jaffray Companies reaffirmed a “buy” rating and issued a $78.00 target price on shares of Henry Schein in a report on Wednesday, December 27th. Deutsche Bank assumed coverage on shares of Henry Schein in a report on Friday, December 8th. They issued a “buy” rating and a $79.00 target price for the company. Finally, Morgan Stanley cut shares of Henry Schein from an “equal weight” rating to an “underweight” rating and set a $88.00 target price for the company. in a report on Wednesday, December 6th. Two investment analysts have rated the stock with a sell rating, seven have given a hold rating and eight have given a buy rating to the stock. Henry Schein currently has an average rating of “Hold” and an average price target of $84.23.
TRADEMARK VIOLATION WARNING: This article was originally published by Markets Daily and is the property of of Markets Daily. If you are viewing this article on another publication, it was illegally copied and reposted in violation of United States and international copyright & trademark laws. The original version of this article can be read at https://www.themarketsdaily.com/2018/01/12/montrusco-bolton-investments-inc-reduces-position-in-henry-schein-inc-hsic.html.
About Henry Schein
Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.